臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions
Active as of 2014-09-19 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="medcation-atc-tw"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem medcation-atc-tw</b></p><a name="medcation-atc-tw"> </a><a name="hcmedcation-atc-tw"> </a><a name="medcation-atc-tw-en-US"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>effectiveDate</td><td>effectiveDate</td><td>http://hl7.org/fhir/concept-properties#effectiveDate</td><td>dateTime</td><td>生效日期</td></tr><tr><td>status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>狀態</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>effectiveDate</b></td><td><b>status</b></td></tr><tr><td style="white-space:nowrap">A10BD27<a name="medcation-atc-tw-A10BD27"> </a></td><td>metformin, linagliptin and empagliflozin</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">A16AB22<a name="medcation-atc-tw-A16AB22"> </a></td><td>avalglucosidase alfa</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">C03DA05<a name="medcation-atc-tw-C03DA05"> </a></td><td>finerenone</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">D11AH08<a name="medcation-atc-tw-D11AH08"> </a></td><td>abrocitinib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">G04BD14<a name="medcation-atc-tw-G04BD14"> </a></td><td>imidafenacin</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">H01AC08<a name="medcation-atc-tw-H01AC08"> </a></td><td>somatrogon</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">H01BA06<a name="medcation-atc-tw-H01BA06"> </a></td><td>argipressin</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">J05AB04<a name="medcation-atc-tw-J05AB04"> </a></td><td>ribavirin</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">J05AX11<a name="medcation-atc-tw-J05AX11"> </a></td><td>elvitegravir</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">J05AX12<a name="medcation-atc-tw-J05AX12"> </a></td><td>dolutegravir</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">J05AX67<a name="medcation-atc-tw-J05AX67"> </a></td><td>ombitasvir, paritaprevir and ritonavir</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">J05AX68<a name="medcation-atc-tw-J05AX68"> </a></td><td>elbasvir and grazoprevir</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01EX22<a name="medcation-atc-tw-L01EX22"> </a></td><td>selpercatinib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01FX18<a name="medcation-atc-tw-L01FX18"> </a></td><td>amivantamab</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE01<a name="medcation-atc-tw-L01XE01"> </a></td><td>imatinib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE03<a name="medcation-atc-tw-L01XE03"> </a></td><td>erlotinib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE06<a name="medcation-atc-tw-L01XE06"> </a></td><td>dasatinib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE10<a name="medcation-atc-tw-L01XE10"> </a></td><td>everolimus</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE11<a name="medcation-atc-tw-L01XE11"> </a></td><td>pazopanib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XE31<a name="medcation-atc-tw-L01XE31"> </a></td><td>nintedanib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XX14<a name="medcation-atc-tw-L01XX14"> </a></td><td>tretinoin</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XX17<a name="medcation-atc-tw-L01XX17"> </a></td><td>topotecan</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XX19<a name="medcation-atc-tw-L01XX19"> </a></td><td>irinotecan</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XX32<a name="medcation-atc-tw-L01XX32"> </a></td><td>bortezomib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L01XX73<a name="medcation-atc-tw-L01XX73"> </a></td><td>sotorasib</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">L04AA52<a name="medcation-atc-tw-L04AA52"> </a></td><td>ofatumumab</td><td>2014-09-19</td><td>active</td></tr><tr><td style="white-space:nowrap">N05CM21<a name="medcation-atc-tw-N05CM21"> </a></td><td>lemborexant</td><td>2014-09-19</td><td>active</td></tr></table></div>
</text>
<url
value="https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw"/>
<version value="2022-10-24"/>
<name value="TWMedcationATC"/>
<title value="臺灣食藥署藥品藥理治療分類ATC碼"/>
<status value="active"/>
<experimental value="false"/>
<date value="2014-09-19"/>
<contact>
<name value="衛生福利部"/>
<telecom>
<system value="url"/>
<value value="https://www.mohw.gov.tw/"/>
</telecom>
<telecom>
<system value="email"/>
<value value="CCYU@mohw.gov.tw"/>
</telecom>
</contact>
<description
value="臺灣食藥署藥品藥理治療分類ATC碼,參照至[藥品藥理治療分類ATC碼資料集](https://data.gov.tw/dataset/9119),資料提供單位:衛生福利部食品藥物管理署。
此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼,為符合國內代碼使用,故將未被定義之代碼另外呈現。
*因原始資料無代碼版本資訊,故使用其「更新日期」作為版本資訊。*"/>
<copyright value="衛生福利部食品藥物管理署"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="27"/>
<property>
<code value="effectiveDate"/>
<uri value="http://hl7.org/fhir/concept-properties#effectiveDate"/>
<description value="生效日期"/>
<type value="dateTime"/>
</property>
<property>
<code value="status"/>
<uri value="http://hl7.org/fhir/concept-properties#status"/>
<description value="狀態"/>
<type value="code"/>
</property>
<concept>
<code value="A10BD27"/>
<display value="metformin, linagliptin and empagliflozin"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="A16AB22"/>
<display value="avalglucosidase alfa"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="C03DA05"/>
<display value="finerenone"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="D11AH08"/>
<display value="abrocitinib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="G04BD14"/>
<display value="imidafenacin"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="H01AC08"/>
<display value="somatrogon"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="H01BA06"/>
<display value="argipressin"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="J05AB04"/>
<display value="ribavirin"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="J05AX11"/>
<display value="elvitegravir"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="J05AX12"/>
<display value="dolutegravir"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="J05AX67"/>
<display value="ombitasvir, paritaprevir and ritonavir"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="J05AX68"/>
<display value="elbasvir and grazoprevir"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01EX22"/>
<display value="selpercatinib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01FX18"/>
<display value="amivantamab"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE01"/>
<display value="imatinib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE03"/>
<display value="erlotinib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE06"/>
<display value="dasatinib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE10"/>
<display value="everolimus"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE11"/>
<display value="pazopanib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XE31"/>
<display value="nintedanib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XX14"/>
<display value="tretinoin"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XX17"/>
<display value="topotecan"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XX19"/>
<display value="irinotecan"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XX32"/>
<display value="bortezomib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L01XX73"/>
<display value="sotorasib"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="L04AA52"/>
<display value="ofatumumab"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
<concept>
<code value="N05CM21"/>
<display value="lemborexant"/>
<property>
<code value="effectiveDate"/>
<valueDateTime value="2014-09-19"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
</concept>
</CodeSystem>